NCT02638103 · Interventional trial
Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
Overall registry status Completed
Phase 3
Conditions Migraine
Delaware Valley sites
- Teva Investigational Site 13554 · Philadelphia, PA · Philadelphia County
- Teva Investigational Site 13591 · Jenkintown, PA · Montgomery County
First posted
Registry updated
Added to the directory